传统日本医学大建中汤改善中风后患者的功能性便秘。
Traditional Japanese medicine daikenchuto improves functional constipation in poststroke patients.
机构信息
Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba Ward, Sendai City, Miyagi 980-8575, Japan ; Department of Kampo Medicine, Tohoku University Hospital, 1-1 Seiryo-Machi, Aoba Ward, Sendai City, Miyagi 980-8574, Japan.
Department of Kampo Medicine, Tohoku University Hospital, 1-1 Seiryo-Machi, Aoba Ward, Sendai City, Miyagi 980-8574, Japan ; Comprehensive Education Center for Community Medicine, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba Ward, Sendai City, Miyagi 980-8575, Japan.
出版信息
Evid Based Complement Alternat Med. 2014;2014:231258. doi: 10.1155/2014/231258. Epub 2014 Jun 25.
Poststroke patients with functional constipation, assessed by the Rome III criteria, from 6 hospitals were recruited in a study on the effects of the traditional Japanese medicine Daikenchuto (DKT) on constipation. Thirty-four patients (17 men and 17 women; mean age: 78.1 ± 11.6 years) were randomly assigned to 2 groups; all patients received conventional therapy for constipation, and patients in the DKT group received 15 g/day of DKT for 4 weeks. Constipation scoring system (CSS) points and the gas volume score (GVS) (the measure of the intestinal gas volume calculated from plain abdominal radiographs) were recorded before and after a 4-week observation period. The total score on the CSS improved significantly in the DKT group compared to the control (P < 0.01). In addition, scores for some CSS subcategories (frequency of bowel movements, feeling of incomplete evacuation, and need for enema/disimpaction) significantly improved in the DKT group (P < 0.01, P = 0.049, and P = 0.03, resp.). The GVS was also significantly reduced in the DKT group compared to the control (P = 0.03). DKT in addition to conventional therapy is effective in treating functional constipation in poststroke patients. This study was a randomized controlled trial and was registered in the UMIN Clinical Trial Registry (no. UMIN000007393).
本研究旨在探讨传统日本药物大建中汤(DKT)对脑卒中后功能性便秘患者的疗效。研究共纳入 6 家医院的 34 名符合罗马 III 标准的脑卒中后功能性便秘患者(男 17 例,女 17 例;平均年龄 78.1±11.6 岁)。所有患者均接受常规便秘治疗,DKT 组患者同时加用 DKT(15g/d)治疗 4 周。观察治疗前后患者的便秘评分系统(CSS)和气体容积评分(GVS)变化。与对照组相比,DKT 组 CSS 总分显著降低(P<0.01),且在排便频率、排便不尽感和灌肠/通便需求等 CSS 亚项评分方面均有显著改善(P<0.01,P=0.049,P=0.03)。同时,DKT 组 GVS 亦显著低于对照组(P=0.03)。与常规治疗相比,DKT 联合常规治疗可显著改善脑卒中后患者的功能性便秘症状。本研究为随机对照试验,注册于 UMIN 临床试验注册数据库(注册号:UMIN000007393)。